How many mg of Mounjaro do you need for weight loss?

Why the decision isn't simply 'take the highest dose'

It is a question our prescribers hear most weeks: patients arrive having read that 15 mg produces the greatest average weight loss and assume that is where they should be. The short answer is that higher doses do tend to produce greater results on average (the SURMOUNT-1 trial, published in the New England Journal of Medicine, reported around 20–21% average body-weight reduction at 15 mg over 72 weeks) but 'on average' is doing a lot of work in that sentence. Some people lose substantial weight at 5 or 7.5 mg and tolerate those doses well. Others need the full 15 mg to see meaningful progress. And some people cannot tolerate the higher steps because nausea or other gastrointestinal effects become too disruptive at speed.

The prescriber's job is to find the dose that works for you, not to push you to the ceiling. That is why the licensed schedule builds in time (roughly four weeks at each level) before moving on. Your body needs that window to recalibrate. Rushing it rarely helps and often makes side effects harder to manage.

You can read more about how Mounjaro dosage for weight loss is approached in practice, including how individual factors shape where you end up on the schedule.

What each stage on the dose ladder is actually doing

Think of the schedule in three broad phases. The 2.5 mg starting strength is a tolerability phase: its job is to introduce tirzepatide to your system and reduce the likelihood of nausea hitting hard in week one. Most people see little weight change here, and that is expected. The 2.5 mg dose page covers what to expect during this opening month in more detail.

The middle range (5, 7.5 and 10 mg) is where most of the therapeutic work tends to happen. Appetite suppression becomes more pronounced, food noise settles, and weight begins to move for most people. Some patients reach a dose in this range that suits them well and stay there; titration is not a competition. If you are curious about the 5 mg step specifically, our 5 mg page has a full breakdown of what the evidence shows at that strength.

The upper range (12.5 mg and 15 mg) is for people who have progressed through the lower steps and need more, or whose prescriber has assessed that a faster climb is appropriate given their clinical picture. The 10 mg step is a useful point of reference before reaching the top end: the evidence for meaningful weight loss at this level is solid, and many patients find it the dose where results consolidate.

Factors your prescriber weighs when deciding your dose

Several things shape where your dose ends up, and almost none of them are visible from the outside. Your starting BMI matters, not because a higher BMI automatically means a higher dose, but because the amount of weight your body needs to shift affects the clinical target. The presence of type 2 diabetes, hypertension, or other weight-related conditions changes the risk-benefit calculation at each step.

Side-effect tolerance is probably the most practical limiting factor. Tirzepatide slows gastric emptying, which is partly why it reduces appetite, but it also causes nausea, loose stools or constipation in many people, particularly after a dose increase. If those effects are significant at 5 mg, there is no clinical advantage to accelerating to 7.5 mg before your system has settled. If you want to understand how each Mounjaro dose is matched to weight loss goals, including why staying at a lower step is sometimes the right call, that page sets it out clearly.

NICE's recommendations for tirzepatide (TA1026) note that if someone has not lost at least 5% of their body weight after six months at the highest tolerated dose, continuing treatment should be reviewed, which is another reason the prescriber monitors progress across the full schedule, not just at the start. The full NICE appraisal is available on the NICE website.

For context on what private treatment costs across the dose range, our Mounjaro price comparison page sets out what the market looks like and what to watch for when comparing providers.

What this means for your clinical assessment

Because dose decisions depend on so many individual variables, there is no page, chart or calculator that can tell you the right number in advance. A prescriber needs to understand your weight history, your existing health conditions, any medicines you take that could interact, and your goals, then follow your progress at each stage.

At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber, not processed automatically. Before any dose increase, your prescriber checks that the previous step has been tolerated and that the weight trajectory justifies moving forward. That review happens before every repeat order, not just at the start. Our clinical team oversees the prescribing model and can answer questions that come up between doses through our 7-day aftercare support.

If you want to understand how tirzepatide as a medicine sits within the broader weight-loss treatment landscape, the weight-loss treatment overview is a good starting point. And when you are ready to have your situation assessed properly, a prescriber is the right person to speak to.

You can speak to our prescribers through a free consultation, no commitment, just a thorough clinical review of whether Mounjaro is right for you and, if so, where to begin.